Showing 391-400 of 2109 results for "".
Sporadic Inclusion Body Myositis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sporadic-inclusion-body-myositis/31556/An update on pathophysiology with diagnostic and treatment implications.Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care
https://practicalneurology.com/programs/cme/navigating-therapy-exploring-fda-approved-treatments-for-effective-aad-care/27101/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
https://practicalneurology.com/programs/cme/innovative-therapeutics-how-pathophysiology-guides-new-aad-treatment-development/27100/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Mapping the Mind: The Pathophysiology That Drives AAD
https://practicalneurology.com/programs/cme/mapping-the-mind-the-pathophysiology-that-drives-aad/27098/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29172/Learn more about the use of high-efficacy DMTs in multiple sclerosis.Understanding Chiari Malformation Comorbidities
https://practicalneurology.com/diseases-diagnoses/headache-pain/understanding-chiari-malformation-comorbidities/31925/Part 2 of this special report reviews the comorbidities and trauma-related aggravation of Chiari type I malformations.Optimizing Outcomes in AAD in Community PCP and LTC Clinics
https://practicalneurology.com/programs/cme/optimizing-outcomes-in-aad-in-community-pcp-and-ltc-clinics/26712/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice
https://practicalneurology.com/programs/cme/building-better-strategies-incorporating-new-aad-treatments-into-clinical-practice/27102/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.AAD Treatment Evolution: The Future of Emerging Therapies
https://practicalneurology.com/programs/cme/aad-treatment-evolution-the-future-of-emerging-therapies/27103/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.